Answers are grounded in this paper and cite their sources.
A patient with azole-refractory thrush-esophagitis responded initially to caspofungin, but the treatment eventually failed. In a murine model, caspofungin was effective against two early isolates for which the MICs of caspofungin were low, but it was less effective against a late isolate for which the MIC of caspofungin was greater. We concluded that there is a correlation between in vivo failure and rising in vitro caspofungin MICs.
No takes yet. Share an insight, caveat, or question.
Hernandez et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: